ChartRow logo
INBX
$95.30+6.14%
as of close, Oct 20, 2026
☾ AH $95.30 +6.14%
PeersMRNALLYMDTUNHJNJTMO
Share this page

Inhibrx Biosciences Inc. total returns by year (including dividends)

As of market close, Oct 20, 2026

Inhibrx Biosciences Inc. total returns by year (2021–2026)#

Inhibrx Biosciences Inc. annual returns by year
YearTotal return
2026YTD
+20.6%
2025
+413.0%
2024
-59.5%
2023
+54.2%
2022
-43.6%
2021
+32.5%
Annualized
+31.8%
2021–2026
Average year
+79.3%
5 full years
Best year
+413.0%
2025
Worst year
-59.5%
2024
Positive years
3/5
60% up

Total return by period#

Annual

Methodology#

Total returns, dividends reinvested, measured on INBX. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.

FAQ#

What is Inhibrx Biosciences Inc.'s average annual return?
Since 2021, Inhibrx Biosciences Inc. (INBX) has returned about 31.8% a year (the compound annual growth rate) and an average calendar-year return of 79.3%.
What were Inhibrx Biosciences Inc.'s best and worst years?
Over 2021–2026, the best year was 2025 (+413.0%) and the worst was 2024 (-59.5%).
How often is Inhibrx Biosciences Inc. up in a year?
3 of the 5 full years since 2021 were positive — about 60% of the time.

More on Inhibrx Biosciences Inc.